RNA in Blood Predicts High Blood Pressure During Pregnancy

Biomarkers in serum correlate with preeclampsia, a condition that can lead to fatal hypertension.

Written byDan Robitzski
| 2 min read
A clinician in a white lab coat sitting in a chair uses an arm cuff to measure the blood pressure of a pregnant patient sitting across from them.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

New research suggests that a simple blood test could allow doctors to screen for preeclampsia, a condition marked by dangerously high blood pressure during pregnancy, far more accurately than they can today.

Preeclampsia is thought to stem from improperly developed blood vessels in the placenta, according to the Mayo Clinic. While it can be asymptomatic, the condition sometimes progresses to eclampsia during pregnancy, which can damage organs including the kidneys, liver, and lungs, and can also cause stroke, cardiovascular disease, and brain injuries. In severe cases, doctors will deliver the baby early in order to save the pregnant parent, which can lead to health complications of its own. A study published in Hypertension last September identified a 15-fold increase in maternal mortality caused by hypertensive disorders between 1979 and 2018, illustrating the need for better diagnostics and treatments.

Research published Wednesday (January 5) in Nature describes a new way to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white image of young man in sunglasses with trees in background

    Dan is an award-winning journalist based in Los Angeles who joined The Scientist as a reporter and editor in 2021. Ironically, Dan’s undergraduate degree and brief career in neuroscience inspired him to write about research rather than conduct it, culminating in him earning a master’s degree in science journalism from New York University in 2017. In 2018, an Undark feature Dan and colleagues began at NYU on a questionable drug approval decision at the FDA won first place in the student category of the Association of Health Care Journalists' Awards for Excellence in Health Care Journalism. Now, Dan writes and edits stories on all aspects of the life sciences for the online news desk, and he oversees the “The Literature” and “Modus Operandi” sections of the monthly TS Digest and quarterly print magazine. Read more of his work at danrobitzski.com.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems